Form SCHEDULE 13D/A ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC May 23, 2025 04:16PM
Acelyrin (SLRN) Reiterates Benefits of Value-Maximizing Combination with Alumis (ALMS) May 1, 2025 01:31PM
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis May 1, 2025 01:30PM
Acelyrin (SLRN) Adopts Limited-Duration Stockholder Rights Plan Mar 13, 2025 07:01AM
ACELYRIN Adopts Limited-Duration Stockholder Rights Plan Mar 13, 2025 07:00AM


Mar 12, 2025 05:58PM Form SCHEDULE 13D/A ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Mar 4, 2025 09:00AM ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger
Feb 27, 2025 07:03PM Form SCHEDULE 13D/A ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Feb 21, 2025 07:21AM Acelyrin (SLRN) Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
Feb 20, 2025 09:00PM ACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
Feb 20, 2025 04:15PM Form SCHEDULE 13D ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC